Coping with the Data Avalanche
Nice Insight
PAP-Q1-17-ED-001Mar 09, 2017
The Data Generation
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAP-Q1-17-IN-001Mar 09, 2017
Big Data: A Big Challenge
Nigel Walker
Nice Insight
PAP-Q1-17-NO-001Mar 09, 2017
Energizing Client Portfolios with Patient-Friendly Dosage Forms
Don Barbieri
SPI Pharma
PAP-Q1-17-CL-001Mar 09, 2017
Continuous Manufacturing: To Be Continued…
Guy Tiene; Roger Viney; Bal Kalirai, Ph.D.; Lukas Utiger, Ph.D; Mark Griffiths; Ian Muir, Ph.D.; Matt Hanson
Nice Insight
PAP-Q1-17-VP-001Mar 09, 2017
Industry Benchmark: Introduction
Nice Insight
PAP-Q1-17-FA-001Mar 09, 2017
Changes in the Wind for the CDMO Market
Steve Kuehn; Cynthia A. Challener, Ph.D.; Emilie Branch; Carrie Cao, Ph.D.
Nice Insight
PAP-Q1-17-FA-002Mar 09, 2017
Spending on Contract Research Services Slowing Down
Steve Kuehn; Cynthia A. Challener, Ph.D.; Emilie Branch; Nice Insight; Carrie Cao, Ph.D.
Nice Insight
PAP-Q1-17-FA-003Mar 08, 2017
Investors May Look Smaller
Steve Kuehn; Cynthia A. Challener, Ph.D.; Emilie Branch; Nice Insight; Carrie Cao, Ph.D.
Nice Insight
PAP-Q1-17-FA-008Mar 08, 2017
Equipment Must Integrate
Steve Kuehn; Emilie Branch; Nice Insight; Carrie Cao, Ph.D.
Nice Insight
PAP-Q1-17-FA-006Mar 08, 2017
Spending on Excipients Grows & Diversifies
Steve Kuehn; Cynthia A. Challener, Ph.D.; Emilie Branch; Nice Insight; Carrie Cao, Ph.D.
Nice Insight
PAP-Q1-17-FA-004Mar 08, 2017
Keeping the Chain Going
Steve Kuehn; Cynthia A. Challener, Ph.D.; Emilie Branch; Nice Insight; Carrie Cao, Ph.D.
Nice Insight
PAP-Q1-17-FA-007Mar 08, 2017
Growth Anticipated for Intermediates
Steve Kuehn; Emilie Branch; Nice Insight; Carrie Cao, Ph.D.
Nice Insight
PAP-Q1-17-FA-005Mar 08, 2017
2017 Top 5 Industry Leader
Nice Insight
PAP-Q1-17-IL-001Mar 08, 2017
Operational Excellence in Outsourced Fill-Finish Services
Guy Tiene; Oskar Gold
Nice Insight
PAP-Q1-17-IC-001Mar 08, 2017
Expanding the Commercial Options for Preparation of Amorphous Solid Dispersions
Márcio Temtem, Ph.D.; João Vicente, Ph.D.
Hovione
PAP-Q1-17-CL-006Mar 08, 2017
Q: How is the Need to Provide Local Drug-Product Supply in Multiple Regions Around the World Impacting Pharmaceutical Manufacturing Facility and Equipment Design?
Pharma's Almanac
PAP-Q1-17-RT-002Mar 08, 2017
Q: What Do CROs/CDMOs Need to Do to Ensure That They Provide Effective Global Support but with Locally Oriented Services?
Pharma's Almanac
PAP-Q1-17-RT-001Mar 08, 2017
Q: What will be the Impact of the Requirements that Drug Manufacturers Gain a Similar Level of Supply Chain Understanding for Excipients as they Must Have for APIs?
William van den Bremer; Ramesh Subramanian, Ph.D.; Dirk Hair; Patricia Rafidison
DFE Pharma
PAP-Q1-17-RT-005Mar 08, 2017
Q: What are the Greatest Challenges Drug Manufacturers Face When Working to Meet the New Requirements for Excipient Supply Chain Security?
Pharma's Almanac
PAP-Q1-17-RT-006Mar 08, 2017